What is a model-based economic evaluation?

Study for the WHEBP Evidence as it Relates to Cost Test. Use flashcards and multiple-choice questions, with explanations and hints. Prepare for your exam efficiently!

Multiple Choice

What is a model-based economic evaluation?

Explanation:
Model-based economic evaluation uses a mathematical framework to estimate long-term costs and outcomes by combining data from multiple sources. It builds a decision-analytic model that simulates how a disease and its treatments unfold over time, capturing costs, health effects, and quality of life across a lengthy horizon, often a lifetime. Data from randomized trials, observational studies, published literature, and expert opinion feed the model, and the approach explicitly explores uncertainty with sensitivity analyses and scenario testing. This method is especially useful for informing value-for-money decisions when long-term effects or downstream costs are important but not fully observed in a single study. Using only trial data limits the analysis to short-term results and specific populations, quick estimates lack methodological rigor, and focusing on short-term costs misses downstream health and cost effects.

Model-based economic evaluation uses a mathematical framework to estimate long-term costs and outcomes by combining data from multiple sources. It builds a decision-analytic model that simulates how a disease and its treatments unfold over time, capturing costs, health effects, and quality of life across a lengthy horizon, often a lifetime. Data from randomized trials, observational studies, published literature, and expert opinion feed the model, and the approach explicitly explores uncertainty with sensitivity analyses and scenario testing. This method is especially useful for informing value-for-money decisions when long-term effects or downstream costs are important but not fully observed in a single study. Using only trial data limits the analysis to short-term results and specific populations, quick estimates lack methodological rigor, and focusing on short-term costs misses downstream health and cost effects.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy